|
|
Jay A. Berzofsky, Masaki Terabe, SangKon Oh, Igor M. Belyakov, Jeffrey D. Ahlers, John E. Janik, John C. Morris
J Clin Invest. 2004;
113(11):1515
doi:10.1172/JCI21926
Abstract |
Full text
| PDF
I
n recent years, great strides in understanding and regulating the immune system have led to new hope for harnessing its exquisite specificity to destroy cancer cells without affecting normal tissues. This review examines the fundamental immunologic advances and the novel vaccine strategies arising from these advances, as well as the early clinical trials studying new approaches to treat or prevent cancer.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(32)
| Title and authors |
Publication |
Year |
Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
Y Chen, Y Xie, T Chan, A Sami, S Ahmed, Q Liu, J Xiang
|
Cancer Gene Ther
|
2011 |
IMMUNOCAT-a data management system for epitope mapping studies.
Jo L Chung, Jian Sun, John Sidney, Alessandro Sette, Bjoern Peters
|
J. Biomed. Biotechnol.
|
2010 |
A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivo.
Patrick Williams, Moutih Rafei, Manaf Bouchentouf, Jennifer Raven, Shala Yuan, Jessica Cuerquis, Kathy A Forner, Elena Birman, Jacques Galipeau
|
Mol. Ther.
|
2010 |
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy
M Wang, L Sun, J Qian, X Han, L Zhang, P Lin, Z Cai, Q Yi
|
Leukemia
|
2009 |
Complete elimination of established neuroblastoma by synergistic action of γ-irradiation and DCs treated with rSeV expressing interferon-β gene
K Tatsuta, S Tanaka, T Tajiri, S Shibata, A Komaru, Y Ueda, M Inoue, M Hasegawa, S Suita, K Sueishi, T Taguchi, Y Yonemitsu
|
Gene Ther
|
2008 |
Dendritic cell subsets in health and disease
Hideki Ueno, Eynav Klechevsky, Rimpei Morita, Caroline Aspord, Tinghua Cao, Toshimichi Matsui, Tiziana Di Pucchio, John Connolly, Joseph W. Fay, Virginia Pascual, A. Karolina Palucka, Jacques Banchereau
|
Immunological Reviews
|
2007 |
Identification of T-cell epitopes for cancer immunotherapy
J H Kessler, C J M Melief
|
Leukemia
|
2007 |
Preparation and Characterization of Innovative Protein-coated Poly(Methylmethacrylate) Core-shell Nanoparticles for Vaccine Purposes
Rebecca Voltan, Arianna Castaldello, Egidio Brocca-Cofano, Giuseppe Altavilla, Antonella Caputo, Michele Laus, Katia Sparnacci, Barbara Ensoli, Silvia Spaccasassi, Marco Ballestri, Luisa Tondelli
|
Pharm Res
|
2007 |
Intra-tumoral Gene Delivery of feIL-2, feIFN-γ and feGM-CSF using Magnetofection as a Neoadjuvant Treatment Option for Feline Fibrosarcomas: A Phase-I Study
A. Jahnke, J. Hirschberger, C. Fischer, T. Brill, R. Köstlin, C. Plank, H. Küchenhoff, S. Krieger, K. Kamenica, U. Schillinger
|
Journal of Veterinary Medicine Series A
|
2007 |
Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice.
Hee-Kap Kang, Yun Jo Chung, Chung Ung Park, Yong-Suk Jang, Byung S Kim
|
Immunology
|
2006 |
|
